Skip to main content

Table 7 CMR findings in patients with normal ECG vs. abnormal ECG

From: T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides

 

ECG normal (n = 26)

ECG abnormal (n = 11)

p

LV-EF (%)

66 ± 9

61 ± 12

0.47

LV-EDV (ml)

116 ± 28

136 ± 60

0.68

LV-ESV (ml)

40 ± 17

59 ± 47

0.46

LV-SV

76 ± 17

77 ± 21

0.79

LV-EDD

47 ± 5

49 ± 6

0.31

LA (cm2)

19 ± 3

23 ± 7

0.16

IVS (mm)

10 ± 2

11 ± 2

0.06

PA (mm)

25 ± 3

25 ± 4

0.80

LV mass (g)

91 ± 23

89 ± 30

0.46

LGE positive (n)

10 (39%)

6 (55%)

0.37

Native T1 (ms)

983 (960–1010)

1006 (983–1037)

0.11

Post-contrast T1 (ms)

487 (464–538)

490 (476–512)

0.62

ECV (%)

26 (25–28)

29 (28–32)

0.01

T2 (ms)

52 (50–54)

55 (53–57)

0.009

  1. All values are n or mean ± SD or interquartile ranges. CMR cardiac magnetic resonance, LV left-ventricular, EF ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, EDD end-diastolic diameter, LA left atrium, IVS interventricular septum, PA pulmonary artery, LGE late gadolinium enhancement, ECV extracellular volume